PDF-AASLD. 2014: Abstract 1939. 3D + Ribavirin for HCV-HIV Coinfection an

Author : sherrill-nordquist | Published Date : 2015-11-21

AASLD 2014 Abstract 1939 3D OmbitasvirParitaprevirRitonavir and Dasabuvir RBV Ribavirin 935 935 938 906 0 20 40 60 80 100 SVR4 SVR12 Patients with SVR 3D RBV

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "AASLD. 2014: Abstract 1939. 3D + Ribavi..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

AASLD. 2014: Abstract 1939. 3D + Ribavirin for HCV-HIV Coinfection an: Transcript

AASLD 2014 Abstract 1939 3D OmbitasvirParitaprevirRitonavir and Dasabuvir RBV Ribavirin 935 935 938 906 0 20 40 60 80 100 SVR4 SVR12 Patients with SVR 3D RBV x 12 Weeks 3D RBV. RESPOND-2. Phase . 3. Treatment. . Experienced. Bacon BR, et al. N . Engl. J Med. 2011;364:1207-17.. Source: . Bacon BR, et al. N Engl J Med. 2011;364:1207-17.. Boceprevir for Retreatment of HCV Genotype 1 Infection . versus . Telaprevir. . with PR in GT1 . ATTAIN Trial. Phase . 3. Treatment. . Experienced. Reddy KR. , . et al. . Lancet Infect Dis. 2015;15:27-35.. Source: Reddy KR. , et al. Lancet Infect Dis. 2015;15:27-35.. NIH SPARE. Phase . 2. Treatment. . Naïve . (unfavorable baseline treatment . characteristics). Osinusi. A, et al. JAMA. 2013;310:804-11.. Source: . Osinusi. A,. . et al. . JAMA. 2013;310:804-11.. HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Trial. Phase . 3. Sulkowski. MS, et al. JAMA. 2014;312:353-61.. Treatment. Naïve and Treatment . Experienced. HIV Coinfection. Source: . Sulkowski. MS, et al. JAMA. 2014;312:353-61.. Co-Infection – Florida, . 2014. . STD and Hepatitis Section in collaboration with HIV/AIDS Section – Surveillance Unit . Division of Disease Control and Health Protection. HIV Disease data from 1981 through December . Update. David Spach, MD. Professor of Medicine, Division of Infectious Diseases. University of Washington. Last Updated: . June 12. , 2013. Chronic Viral Diseases and Mortality in United States. Which one of the chronic viral diseases was responsible for the most number of deaths in the United States in 2007?. 30. 40. 50. 60. 70. 80. 90. 1. 00. 0 . 1. 0. . 20. Days Since. . Infection. HIV RNA. . (plasma). HIV. . Antibody. HIV p24. . Ag. IgM. IgG. FIGURE . 1: LABORATORY . MARKERS . OF HIV. . INFECTION. NIAID Retreatment. Phase . 2a . Treatment. . Experienced. Osinusi. A, . et al. . Ann Intern Med. 2014;161:634-8.. Source: . Osinusi. A, et al. Ann Intern Med. 2014;161:634-8.. Ledipasvir-Sofosbuvir Retreatment of SOF RBV Failure in HCV GT 1. University of Chicago. Chicago, Illinois. Challenges in the Management and Treatment of HIV/Hepatitis C Virus Coinfection. FORMATTED: 05/02/2016. Chicago, Illinois: May 9, 2016. From . AI . Aronsohn. Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence Phase 2 Curry MP, et al. Gastroenterology . 2015;148:100-7. Treatment Naïve and Treatment Experienced Liver Transplantation Source: Curry MP, et Genotype 1, never treated for HCV, no cirrhosis12 weeks (recommended): to (if HCV RNA is less than 6 million copies IU/mL, consider 8 weeks8 weeks: (if HCV RNA is less than 6 million copies IU/mL: 9 SPRINT. -1. Phase . 2. Treatment. . Naïve. Kwo. PY, et al. Lancet. 2010;376:705-16.. Source: . Kwo PY, et al. Lancet. 2010;376:705-16. .. Boceprevir . for Treatment-Naïve HCV Genotype 1. SPRINT. Following Liver Transplantation. Phase 2. Charlton M, . et al. . Gastroenterology. 2015;148:108-17.. Treatment. Naïve and Treatment . Experienced. Liver Transplantation. Source: Charlton M, et al. Gastroenterology. 2015;148:108-17.. GT-1. C212 Trial. Phase . 3. Treatment. Naïve and Treatment . Experienced. Dieterich. . D. , et al. . Clin. Infect Dis. 2014;59:1579-87.. HIV Coinfection. Source: . Dieterich. D. , et al. . Clin.

Download Document

Here is the link to download the presentation.
"AASLD. 2014: Abstract 1939. 3D + Ribavirin for HCV-HIV Coinfection an"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.